Articles From: Vail Resorts Announces Fiscal 2014 Year-End Earnings Release Date to Valerie Haertel Appointed Global Head of Investor Relations at BNY Mellon; Brings Two Decades of Senior Level Financial and Management Experience, Including State Street and Alliance Bernstein


BROOMFIELD, Colo.
Sign-up for Vail Resorts Announces Fiscal 2014 Year-End Earnings Release Date investment picks
-- Blaise Carrig to step down as president of mountain division to a senior advisor role -- Patricia Campbell to succeed Carrig as president of mountain division -- John Buhler to succeed Campbell as COO of Breckenridge --
Sign-up for Vail Resorts Announces Planned Leadership Succession Changes in Its Mountain Division investment picks
- Vail Resorts promotes Beth Howard to be General Manager of Northstar California Resort BROOMFIELD, Colo.
Sign-up for Vail Resorts Names Bill Rock, Chief Operating Officer of Northstar California Resort and Industry Veteran, to Oversee Park City Mountain Resort and Canyons Resort investment picks
2014/9/17
- EpicPromise expands Vail Resorts' leadership in sustainability by engaging guests, local communities and employees in the commitment to create a more promising future.
Sign-up for Vail Resorts Strengthens Commitment to Sustainability with Launch of EpicPromise investment picks
Valeant And Pershing Square May Vote At Special Meeting -Special meeting will go forward as previously scheduled - Ruling allows Valeant, Pershing Square and other Allergan shareholders to vote out a majority of the Allergan board at the December 18 Special Meeting Canada NewsWire LAVAL, Quebec , Nov.
Sign-up for Valeant And Pershing Square May Vote At Special Meeting investment picks
-Special meeting will go forward as previously scheduled - Ruling allows Valeant, Pershing Square and other Allergan shareholders to vote out a majority of the Allergan board at the December 18 Special Meeting LAVAL, Quebec , Nov.
Sign-up for Valeant And Pershing Square May Vote At Special Meeting investment picks
Valeant Delivers Letter To Allergan Board Canada NewsWire · Prepared to Improve Offer And Provide Value of at Least $200 a Share · Urges Allergan Board to Take Control of Process LAVAL, Quebec , Oct.
Sign-up for Valeant Delivers Letter To Allergan Board investment picks
· Prepared to Improve Offer And Provide Value of at Least $200 a Share · Urges Allergan Board to Take Control of Process LAVAL, Quebec , Oct.
Sign-up for Valeant Delivers Letter To Allergan Board investment picks
LAVAL, Quebec , Aug.
Sign-up for Valeant Extends Offer To Acquire Allergan investment picks
2014/10/27
By Michael Calia Valeant Pharmaceuticals International Inc. hinted at the prospect of a higher takeover offer for Botox maker Allergan Inc., which raised its guidance for the year on Monday, as both companies angle for shareholder support ahead of a key deadline.
Sign-up for Valeant Hints at Higher Allergan Bid -- 2nd Update investment picks
2014/10/27
By Michael Calia Allergan Inc. and Valeant Pharmaceuticals International Inc. continued to raise the stakes Monday as their takeover battle approaches a key deadline.
Sign-up for Valeant Hints at Higher Allergan Bid -- 3rd Update investment picks
2014/10/27
By Michael Calia Allergan Inc. and Valeant Pharmaceuticals International Inc. continued to raise the stakes Monday as their takeover battle approaches a key deadline.
Sign-up for Valeant Hints at Higher Allergan Bid -- 4th Update investment picks
2014/10/27
By Michael Calia And Joseph Walker Allergan Inc. and Valeant Pharmaceuticals International Inc. continued to raise the stakes Monday as their takeover battle approaches a key deadline.
Sign-up for Valeant Hints at Higher Allergan Bid -- 5th Update investment picks
2014/10/27
By Michael Calia And Joseph Walker Allergan Inc. and Valeant Pharmaceuticals International Inc. continued to raise the stakes Monday as their takeover battle approaches a key deadline.
Sign-up for Valeant Hints at Higher Allergan Bid -- 6th Update investment picks
By Lauren Pollock and Chelsey Dulaney Valeant Pharmaceuticals International Inc. said it expects to report stronger-than-expected results for its third quarter and continued its push to bring Botox maker Allergan Inc. to the negotiating table as their takeover battle enters its fifth month.
Sign-up for Valeant offers olive branch to Allergan investment picks
2014/9/8
Hosted Ribbon Cutting Ceremony for the New Bausch + Lomb ULTRA® Contact Lens Manufacturing Line and Solar Array Implementation LAVAL, Quebec , Sept.
Sign-up for Valeant Pharmaceuticals Expands Bausch + Lomb Manufacturing Facility, Adding 120 New Jobs in Rochester investment picks
Valeant Pharmaceuticals Reports Third Quarter 2014 Financial Results Canada NewsWire LAVAL, Quebec , Oct.
Sign-up for Valeant Pharmaceuticals Reports Third Quarter 2014 Financial Results investment picks
LAVAL, Quebec , Oct.
Sign-up for Valeant Pharmaceuticals Reports Third Quarter 2014 Financial Results investment picks
2014/11/7
LAVAL, Quebec , Nov.
Sign-up for Valeant Pharmaceuticals Sends Letter To Physician Customers investment picks
2014/11/7
Valeant Pharmaceuticals Sends Letter To Physician Customers Canada NewsWire LAVAL, Quebec , Nov.
Sign-up for Valeant Pharmaceuticals Sends Letter To Physician Customers investment picks
Valeant Pharmaceuticals To Announce 2014 Third Quarter Results On October 20, 2014 Canada NewsWire LAVAL, Quebec , Oct.
Sign-up for Valeant Pharmaceuticals To Announce 2014 Third Quarter Results On October 20, 2014 investment picks
LAVAL, Quebec , Oct.
Sign-up for Valeant Pharmaceuticals To Announce 2014 Third Quarter Results On October 20, 2014 investment picks
LAVAL, Quebec , Sept.
Sign-up for Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA investment picks
Overall Same Store Organic Growth (unadjusted for generics) Expected to Exceed 15% in Third Quarter Bausch + Lomb Expected to Continue to Deliver Greater Than 10% Organic Growth (unadjusted) Valeant 3Q Results Expected to Beat Consensus on Revenue and Be Better than Guidance on Cash EPS, Organic Growth, Restructuring Charges and Adjusted Cash Flow from Operations Expect Continued Strong Double-digit Same Store Organic Growth in the Fourth Quarter Will Announce Third Quarter Results on October 20 LAVAL, Quebec , Sept.
Sign-up for Valeant Provides Update On Third Quarter Results And Sends Letter To Allergan CEO And Lead Independent Director investment picks
Valeant Pharmaceuticals International Inc. (VRX) and partner Pershing Square Capital Management plan to boost their bid for Allergan Inc. (AGN) by $15 a share, The Wall Street Journal reported late Tuesday, citing unnamed sources.
Sign-up for Valeant to boost Allergan bid by $15 a share: report investment picks
Allergan Inc. shares (AGN) rose more than 3% in premarket trade Monday, after Valeant Pharmaceuticals International Inc. (VRX) said it was prepared to improve its offer for Allergan to a value of at least $200 a share.
Sign-up for Valeant willing to improve Allergan offer to value of at least $200 a share investment picks
Valener and Gaz Métro fiscal year 2014 results release and conference call Canada NewsWire MONTRÉAL, Oct.
Sign-up for Valener and Gaz Métro fiscal year 2014 results release and conference call investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Vail Resorts Announces Fiscal 2014 Year-End Earnings Release Date to Valerie Haertel Appointed Global Head of Investor Relations at BNY Mellon; Brings Two Decades of Senior Level Financial and Management Experience, Including State Street and Alliance Bernstein
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent